PEMETREXED
| Brand name | PEMFEXY |
|---|---|
| Active ingredient | PEMETREXED |
| Strength | 500MG/20ML (25MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | February 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12115164 | February 2036 | use U-4248 |
| 11793813 | February 2036 | product |
| 9604990 | October 2035 | substance |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.